156 related articles for article (PubMed ID: 32606095)
41. A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention.
Nowakowski A; Arbyn M; Turkot MH; Wieszczy P; Miłosz K; Kamiński MF; Didkowska J; Bidziński M; Olszewski W; Wielgoś M; Krzakowski M; Kuchar E; Walewski J
Eur J Cancer Prev; 2020 Mar; 29(2):157-164. PubMed ID: 31517672
[TBL] [Abstract][Full Text] [Related]
42. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
Hall MT; Simms KT; Murray JM; Keane A; Nguyen DTN; Caruana M; Lui G; Kelly H; Eckert LO; Santesso N; de Sanjose S; Swai EE; Rangaraj A; Owiredu MN; Gauvreau C; Demke O; Basu P; Arbyn M; Dalal S; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3059-3066. PubMed ID: 38087116
[TBL] [Abstract][Full Text] [Related]
43. Cervical Awareness Rabbit (CARA).
Zhou F; Marcus A
Int J Surg Pathol; 2021 May; 29(3):300. PubMed ID: 32423263
[No Abstract] [Full Text] [Related]
44. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
Nyabigambo A; Mayega RW; Ginindza TG
Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
[TBL] [Abstract][Full Text] [Related]
46. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of a culturally tailored text messaging program for promoting cervical cancer screening in accra, Ghana: a quasi-experimental trial.
Addo-Lartey AA; Bonful HA; Sefenu RS; Abagre TA; Asamoah A; Bandoh DA; Awua AK; Adu-Aryee NA; Dedey F; Adanu RMK; Okuyemi KS
BMC Womens Health; 2024 Jan; 24(1):22. PubMed ID: 38172883
[TBL] [Abstract][Full Text] [Related]
48. Willingness to HPV self-sampling for cervical cancer screening and its predictors among women attending outpatient clinics in Meru District, Arusha Region, Northern Tanzania.
Oneko O; Mahande MJ; Amour C; Pollie M; Smith C; Mboya IB; Finkel M
Afr Health Sci; 2022 Jun; 22(2):97-106. PubMed ID: 36407363
[TBL] [Abstract][Full Text] [Related]
49. Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador.
Alfaro K; Maza M; Felix JC; Gage JC; Castle PE; Alonzo TA; Chacón A; González E; Soler M; Conzuelo-Rodriguez G; Masch R; Cremer M
JCO Glob Oncol; 2020 Oct; 6():1519-1530. PubMed ID: 33064628
[TBL] [Abstract][Full Text] [Related]
50. Experiences with thermal ablation for cervical precancer treatment after self-collection HPV-based screening in the ASPIRE Mayuge randomized trial.
Gottschlich A; Payne BA; Trawin J; Albert A; Jeronimo J; Mitchell-Foster S; Mithani N; Namugosa R; Naguti P; Orem J; Rawat A; Simelela PN; Singer J; Smith LW; van Niekerk D; Nakisige C; Ogilvie G
Int J Cancer; 2023 Apr; 152(8):1630-1639. PubMed ID: 36408923
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.
Thomsen LT; Kjær SK
BMC Med; 2021 Jul; 19(1):165. PubMed ID: 34261466
[No Abstract] [Full Text] [Related]
52. Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status.
Johnson CY; Sharp L; Cotton SC; Harris CA; Gray NM; Little J;
PLoS One; 2011; 6(6):e21046. PubMed ID: 21698168
[TBL] [Abstract][Full Text] [Related]
53. Implementing community-based human papillomavirus self-sampling with SMS text follow-up for cervical cancer screening in rural, southwestern Uganda.
Joseph NT; Namuli A; Kakuhikire B; Baguma C; Juliet M; Ayebare P; Ahereza P; Tsai AC; Siedner MJ; Randall TR; Ngonzi J; Boatin AA
J Glob Health; 2021; 11():04036. PubMed ID: 35003710
[TBL] [Abstract][Full Text] [Related]
54. Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus-based cervical screening program: A cross-sectional survey.
Chadwick V; Bennett KF; McCaffery KJ; Brotherton JML; Dodd RH
Psychooncology; 2022 Jul; 31(7):1110-1119. PubMed ID: 35128756
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus self-testing among unscreened and under-screened Māori, Pasifika and Asian women in Aotearoa New Zealand: A preference survey among responders and interviews with clinical-trial nonresponders.
Sherman SM; Brewer N; Bartholomew K; Bromhead C; Crengle S; Cunningham C; Douwes J; Foliaki S; Grant J; Maxwell A; McPherson G; Scott N; Wihongi H; Potter JD
Health Expect; 2022 Dec; 25(6):2914-2923. PubMed ID: 36161964
[TBL] [Abstract][Full Text] [Related]
56. Provision of cervical cancer services for women living with HIV, Uganda.
Kalamya JN; DeCuir J; Alger SX; Ninsiima J; Kabanda J; Komakech P; Lubega M; Nantege G; Birabwa E; Nyombi TN; Namukanja P; Baveewo S; Ssendiwala J; Calnan J; Mwangi C; Nakawuka M; Mutungi G; Nelson LJ; Dirlikov E
Bull World Health Organ; 2024 Jun; 102(6):382-388. PubMed ID: 38812805
[TBL] [Abstract][Full Text] [Related]
57. Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England.
Nemec M; Waller J; Barnes J; Marlow LAV
BMJ Open; 2022 May; 12(5):e058635. PubMed ID: 35508345
[TBL] [Abstract][Full Text] [Related]
58. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Koh WJ; Abu-Rustum NR; Bean S; Bradley K; Campos SM; Cho KR; Chon HS; Chu C; Clark R; Cohn D; Crispens MA; Damast S; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; Han E; Huh WK; Lurain JR; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Ueda S; Wyse E; Yashar CM; McMillian NR; Scavone JL
J Natl Compr Canc Netw; 2019 Jan; 17(1):64-84. PubMed ID: 30659131
[TBL] [Abstract][Full Text] [Related]
59. Point-of-care tests for human papillomavirus detection in uterine cervical samples: A review of advances in resource-constrained settings.
Gupta R; Gupta S
Indian J Med Res; 2023 Nov; 158(5&6):509-521. PubMed ID: 38236008
[TBL] [Abstract][Full Text] [Related]
60. Women's acceptability of a self-collect HPV same-day screen-and-treat program in a high burden setting in the Pacific.
Camara H; Nosi S; Munnull G; Badman SG; Bolgna J; Kuk J; Mola G; Guy R; Vallely AJ; Kelly-Hanku A
BMC Health Serv Res; 2022 Dec; 22(1):1514. PubMed ID: 36510192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
